SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001626199-24-000101
Filing Date
2024-05-20
Accepted
2024-05-20 20:14:39
Documents
1
Period of Report
2024-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716250468.html 4  
1 FORM 4 wk-form4_1716250468.xml 4 20956
  Complete submission text file 0001626199-24-000101.txt   22636
Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD, #200 SOUTH SAN FRANCISCO CA 94080
Business Address
Peetz Christopher (Reporting) CIK: 0001614740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 24966592

Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)